LRRC3B Antibody (FITC)

Este producto es parte de LRRC - Leucine-rich repeat-containing protein
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
LRRC3B Antibody (FITC)
category
Primary Antibodies
provider
Abbexa
reference
abx310508

Description

LRRC3B Antibody (FITC) is a Rabbit Polyclonal against LRRC3B conjugated to FITC.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
LRRC3B
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
FITC
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q96PB8
Gene ID
116135
Alias
LRRC3B, LRP15,Leucine-rich repeat protein 15
Background
Antibody anti-LRRC3B
Status
RUO

Descripción

LRRC3B is a tumor suppressor protein expressed in various tissues where it modulates cell growth and apoptosis its expression is frequently downregulated in cancers such as gastric colorectal and breast cancer due to epigenetic silencing through promoter hypermethylation LRRC3B is believed to inhibit cancer progression by modulating Wnt/β-catenin signaling and other pathways involved in cell proliferation and survival loss of LRRC3B function contributes to tumorigenesis by disrupting cell cycle regulation and enhancing cellular migration and invasion studies indicate it may also influence the tumor microenvironment by regulating extracellular matrix remodeling and cell-cell adhesion its potential as a biomarker for early cancer detection and prognosis is being actively explored as is its reactivation through epigenetic therapies targeting promoter methylation further research is necessary to fully characterize its tumor-suppressive mechanisms and therapeutic applications in oncology

Related Products

Pr23099

Recombinant Human LRRC3B

Ver Producto
abx302045

Leucine-Rich Repeat-Containing Protein 3B (LRRC3B) Antibody

LRRC3B Antibody is a Rabbit Polyclonal against LRRC3B.

Ver Producto
abx310507

LRRC3B Antibody (HRP)

LRRC3B Antibody (HRP) is a Rabbit Polyclonal against LRRC3B conjugated to HRP.

Ver Producto